|
|
ABOUT US
Management Team
 |
Dr. Mike Sabolinski, MD - Chief Executive Officer
Dr. Sabolinski has more than 25 years of experience in wound care as a Scientist, Investigator, and Sponsor of investigations for the treatment of patients with acute and chronic wounds. He joined Organogenesis, Inc., Canton, MA in 1992, and completed a decade long career where he held several positions including President and Chief Executive Officer. At Organogenesis, he led the Company to two FDA approvals of a living skin substitute, the first living manufactured organ to be globally sold and marketed (Organogenesis, Inc. and Novartis International AG, Basel, Switzerland). Dr. Sabolinski also worked at FoxKiser LLP, Washington, DC a firm that employs a multi-disciplinary approach to health care. In Cardiovascular medicine, he served as Chief Medical Officer of NitroMed, Inc., Lexington, MA and managed the clinical and regulatory drug approval process of Bidil®, the first and only drug to receive an Indication for Use exclusively in African Americans. He earned his M.D. from the State University of New York at Buffalo and a M.S. in Biochemistry from New York University Graduate School of Arts and Sciences.
|
 |
Dr. Liora Braiman-Wiksman, Ph.D. - VP R&D
Dr. Braiman received her PhD in biochemistry and cellular biology from the Faculty of Life Sciences, Bar Ilan University, Israel. Dr. Braiman has vast experience in biochemistry, cellular biology and molecular biology. Previously, Dr. Braiman was the Head of the Molecular and Functional Unit of the diabetes project at QBI Inc. Dr. Braiman heads HealOr's research and development.
|
 |
Dr. Yuval Sagiv, Ph.D - Head of Preclinical Development
Dr. Sagiv received his PhD from the department of biological chemistry, The Weizmann Institute of Science, Israel. Dr. Sagiv has served as a post-doctoral scholar at the University of Chicago, IL, USA, studying the mechanisms of lipid presentation to the immune system and their effect on Th1/Th2 immunological responses. Before joining HealOr, Dr. Sagiv has served as the head of research in Target-In Ltd. Dr. Sagiv brings to HealOr vast experience in the fields of immunology, biochemistry, molecular biology and animal model development.
|
 |
Dr.Boris Visman, Ph.D - VP Chemistry and Manufacturing Control (CMC)
Dr. Visman received his PhD in pharmacy and pharmaceutical chemistry from the Faculty of Medicine, Hebrew University of Jerusalem, Israel. He is an experienced specialist in development of novel formulations, manufacturing control, QA and QC management, drug discovery and regulatory affairs. Before joining HealOr, Dr. Visman has held senior positions at BioLine RX, Rafa laboratories Ltd. and Juvenis Biomed.
|
 |
Mr. Haim Bar Zik - CFO
Mr. Bar Zik brings to HealOr more than 18 years of executive management experience, primarily in the Hi-Tech sector. Mr. Bar Zik was with A.B. Data for more than twelve years serving as CFO and later as CEO. Most recently Mr. Bar Zik was CFO of Xor Technologies.
|
 |
Dr. Revital Mandil – Levin, PhD, MBA - Head of Business Development
Dr. Mandil-Levin brings to HealOr an extensive experience in business development and strategic alliances in the field of biotech startups. She was formerly business development manager at Proteologics Ltd. Dr. Mandil-Levin holds a PhD in biochemistry from Bar-Ilan University and an MBA form the Israeli College of Management- Technology Company Management Program.
|
|
|
